MAX Chat
Company Analysis Takeda Pharmaceutical Company Limited
1. Summary
Advantages
- Dividends (6.84%) are higher than the sector average (1.61%).
- The stock's return over the last year (20.02%) is higher than the sector average (-20.37%).
- Current debt level 31.69% is below 100% and has decreased over 5 years from 41.46%.
Disadvantages
- Price (31 $) is higher than fair price (30.88 $)
- The company's current efficiency (ROE=1.56%) is lower than the sector average (ROE=14.32%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Takeda Pharmaceutical Company Limited | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | 0.5% | 2% |
| 90 days | 9.3% | -23% | 9.8% |
| 1 year | 20% | -20.4% | 17.3% |
TKPHF vs Sector: Takeda Pharmaceutical Company Limited has outperformed the "Healthcare" sector by 40.39% over the past year.
TKPHF vs Market: Takeda Pharmaceutical Company Limited has outperformed the market by 2.7% over the past year.
Stable price: TKPHF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: TKPHF with weekly volatility of 0.3849% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (31 $) is higher than the fair price (30.88 $).
Price is higher than fair: The current price (31 $) is 0.4% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0.4611) is lower than that of the sector as a whole (46.56).
P/E vs Market: The company's P/E (0.4611) is lower than that of the market as a whole (46.13).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.0072) is lower than that of the sector as a whole (5.34).
P/BV vs Market: The company's P/BV (0.0072) is lower than that of the market as a whole (4.36).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.0109) is lower than that of the sector as a whole (4.29).
P/S vs Market: The company's P/S indicator (0.0109) is lower than that of the market as a whole (12.96).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (10.88) is lower than that of the sector as a whole (17.57).
EV/Ebitda vs Market: The company's EV/Ebitda (10.88) is lower than that of the market as a whole (27.25).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Rising and has grown by 28.79% over the last 5 years.
Earnings Slowdown: The last year's return (-25.08%) is below the 5-year average return (28.79%).
Profitability vs Sector: The return for the last year (-25.08%) is lower than the return for the sector (-1.77%).
5.4. ROE
ROE vs Sector: The company's ROE (1.56%) is lower than that of the sector as a whole (14.32%).
ROE vs Market: The company's ROE (1.56%) is lower than that of the market as a whole (52.17%).
5.5. ROA
ROA vs Sector: The company's ROA (0.7575%) is lower than that of the sector as a whole (7.27%).
ROA vs Market: The company's ROA (0.7575%) is lower than that of the market as a whole (36.33%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (3.51%) is lower than that of the sector as a whole (14.12%).
ROIC vs Market: The company's ROIC (3.51%) is lower than that of the market as a whole (10.84%).
7. Dividends
7.1. Dividend yield vs Market
High yield: The dividend yield of the company 6.84% is higher than the average for the sector '1.61%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 6.84% has been steadily paid over the past 7 years, DSI=0.71.
Weak dividend growth: The company's dividend yield 6.84% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (280.28%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
